Business
Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member
Aphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member.
About this update from Sunset Capital Assets, Inc.
[{"type":"text","content":"\n\n\n\nAphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAphex BioCleanse Systems Appoints Tom Fitzgerald as Chairman of the Board; Adds Scott Buckley as New Board Member\nPR Newswire\nPITTSFORD, N.Y., Sept. 29, 2021\n\n\n\n\n \n \n \n PITTSFORD, N.Y., Sept. 29, 2021 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) (\"Aphex\" or \"the Company\"), a cleaning solutions company focused on the development and distribution of non-toxic and water-based cleaning products trademarked with Hy-IQ® Water, today announced that the Company has appointed Tom Fitzgerald as Chairman of the Board and Director of Operations Scott Buckley as a member of the Board of Directors.\n\n \n \n \n \n \n \n\n \n\"I believe Aphex has a unique opportunity to change the landscape of cleaning products through its proprietary, non-toxic cleaning solution, Hy-IQ® Water,\" said Tom Fitzgerald, Aphex's newly appointed Chairman of the Board. \"I plan to leverage my years of experience working with regulatory bodies and large, publicly traded companies in the life sciences sector in order to take Aphex to the next level. I hope to assist the Aphex management team and Board of Directors with filling the imminent market need for environmentally-friendly, safe sanitization products.\"\nFitzgerald is a seasoned business professional and visionary leader with more than 35 years of experience as an attorney, senior executive and consultant in the biopharmaceutical and consumer products industries. He has held numerous positions on the Board of Directors for both public and private domestic and international entities and has led a variety of companies to pursue regulatory and legal compliance approvals for a variety of products, prescription drugs, over-the-counter (OTC) medicines, medical devices and drug delivery systems. He has also managed joint ventures and strategic alliances between major pharmaceutical companies and accredited manufacturing facilities in the U...